Pfizer has a risky way back into a deal with AstraZeneca. An apparent loophole in Britain’s takeover code means that the American pharmaceutical giant could offer the 58.85 pounds-a-share demanded by Astra for a recommendation, even after declaring that the earlier £55-a-share pitch was “final.”
Help employers find you! Check out all the jobs and post your resume.
